4
Changes in Ownership
RIGEL PHARMACEUTICALS INC Filed Acc 0000905148-26-002811
EVP & Chief Financial Officer acquired 3,381 shares (option exercise)
- EVP & Chief Financial Officer gave up 928 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schorno Dean L EVP & Chief Financial Officer | 2026-06-01 | Option exercise | +1,200 | $18.70 | $22,440 | 77,537 | D |
| Schorno Dean L EVP & Chief Financial Officer | 2026-06-01 | Option exercise | +2,181 | $12.70 | $27,699 | 79,718 | D |
| Schorno Dean L EVP & Chief Financial Officer | 2026-06-01 | Shares withheld for taxes | −928 | $29.86 | $27,710 | 78,790 | D |
| Derivatives | |||||||
| Schorno Dean L EVP & Chief Financial Officer | 2026-06-01 | Option exercise · Employee Stock Option (right to buy) | −1,200 | 9,632 | D | ||
| Schorno Dean L EVP & Chief Financial Officer | 2026-06-01 | Option exercise · Employee Stock Option (right to buy) | −2,181 | 13,518 | D | ||
Loading xslF345X06/form4.xml…